Real Time Touch

new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Real Time Touch

Boston Medical Center Corporation patents

Recent patent applications related to Boston Medical Center Corporation. Boston Medical Center Corporation is listed as an Agent/Assignee. Note: Boston Medical Center Corporation may have other listings under different names/spellings. We're not affiliated with Boston Medical Center Corporation, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Boston Medical Center Corporation-related inventors

Macroinitiators for hydrophilic coatings on latex and applications thereof

Provided herein are methods comprising the use of a macroinitiator and application protocols to apply a hydrophilic coating to latex, or natural rubber, and compositions resulting from such methods. This coating results in e.g., an increased sense of lubrication when in contact with water or an aqueous solution.. ... Boston Medical Center Corporation

Predictive marker for topoisomerase i inhibitors

The present invention generally relates to the fields of cancer therapy and cancer prevention. More particularly, the present invention generally relates to a diagnostic marker for predicting the efficacy of topoisomerase i (topo i) inhibitors in the treatment of cancers. ... Boston Medical Center Corporation

Parkinsons disease model and methods

This application provides a novel mouse model (pla2g6 koex2) in which genetic deletion of the n terminus of pla2g6 results in a loss of dopaminergic (da) neurons in substantia nigra (sn), and development of pd-like motor deficits that can be significantly improved by l-dopa. Based in part on experimental results demonstrated with this model, this disclosure provides genetically modified animals and genetically modified animal cells that comprise a mutant allele of pla2g6 and in which store-operated ca2+ entry (soce) is impaired and er ca2+ stores are depleted. ... Boston Medical Center Corporation

Robo2 inhibitory compositions comprising slit2-binding extracellular domain of robo2

Provided herein are methods for the treatment of chronic kidney disease and proteinuria and for the diagnosis of chronic kidney disease and monitoring the effects of treatment on the progression of chronic kidney disease and proteinuria based on unexpected roles for the slit-robo signaling pathway in the regulation of podocyte f-actin cytoskeleton and foot process structure in the kidney.. . ... Boston Medical Center Corporation

Aqueous contrast agents for dynamic mri and mra

In a first aspect this invention provides methods comprising administering an aqueous contrast agent to the vascular system of a subject, and performing a magnetic resonance scan to detect the mr signal enhancement effects of the aqueous contrast agent. In embodiments the magnetic resonance scan comprises applying at least one pulse sequence selected from a pd-weighted pulse sequence, a t1-weighted pulse sequence, a t2-weighted pulse sequence, and a d-weighted pulse sequence. ... Boston Medical Center Corporation

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Boston Medical Center Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Boston Medical Center Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by